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Inhibition by rapamycin of ornithine decarboxylase and epithelial
cell proliferation in intestinal IEC-6 cells in culture
1E.R. Seidel & V.L. Ragan
Department of Physiology, School of Medicine, East Carolina University Greenville, NC 27858, U.S.A.
1 Induction of the enzyme ornithine decarboxylase (ODC) appears to be controlled primarily at the
level of ODC mRNA translation. The immunosuppressant drug, rapamycin, blocked the induction of
ODC in response to serum by roughly 50% but was without eect on transport of putrescine into the
intracellular space. The eect on ODC was specific for the intracellular signalling pathway leading to
activation of p70S6k, as the immunosuppressant FK 506 was without eect on ODC activity.
2 Exposure of IEC-6 duodenal epithelial cells to rapamycin inhibited cellular proliferation. The eect
of rapamycin was cytostatic in that removal of the immunosuppressant from the medium resulted in
renewed cell division. Conversely, addition of exogenous putrescine, the product of the ODC catalysed
reaction, was unable to reverse the cytostatic eects of rapamycin.
3 At a concentration of 10 nM, rapamycin inhibited the induction of ODC by 50%, a level of inhibition
which could not be enhanced by exposure cells to 1000 nM rapamycin. This observation suggests that
other intracellular signalling pathways, in addition to the p70S6k cascade, might be involved in regulation
of translation of ODC mRNA or that rapamycin does not completely inhibit p70S6k.
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Introduction
Ornithine decarboxylase (ODC), one of the rate limiting en-
zymes in the polyamine biosynthetic pathway, is transiently
induced after exposure to a number growth factors or hor-
mones. There is little or no constitutive expression of the en-
zyme in mammalian systems and enzyme induction is tightly
regulated by a complex set of regulatory mechanisms. In the
duodenal epithelial cell, IEC-6, the ODC protein may be in-
duced 25 fold by exposure of G0/G1 arrested cells to growth
promoting agents (Ginty et al., 1990). While protein levels
increase by 25 fold, the ODC mRNA level increases by only
two fold or less. Indeed, during treatment with putrescine, the
product of the ODC catalyzed reaction, ODC mRNA levels
are still relatively high although ODC protein falls to un-
detectable levels. Likewise, after induction, ODC protein sta-
bility increases by only a factor of three. Thus, control of
induction appears to be primarily at the level of translation.
The 5'-untranslated region (UTR) of the ODC message con-
tains a 130 base GC-rich sequence predicted to form a stable
stem-loop structure which is both necessary and sucient for
repression of ODC mRNA translation (Manzella & Black-
shear, 1990; Grens & Scheer, 1990).
The eukaryotic initiation factor eIF-4F participates in the
melting of mRNA secondary structures. eIF-4F consists of
three subunits, a high molecular weight protein, p220, eIF-4A
(an RNA helicase) and eIF-4E which binds to the 5' cap
structure of mammalian mRNAs (Thach, 1992). Over-
expression of eIF-4E increases the translational eciency of
mRNAs containing extensive secondary structure including
ODC mRNA (Koromilas et al., 1992; Rousseau et al., 1996).
The ability of the ODC 5' UTR to repress translation has been
demonstrated in a growth hormone reporter system. Plasmids
constructed to include sequences of the ODC 5' UTR and a
growth hormone reporter gene demonstrated that insulin sti-
mulation of growth hormone translation was inhibited by
constructs containing either the complete ODC 5' UTR or the
5'-most 115 bases which contain the stem loop structure.
Equally important, the same experiments demonstrated that
insulin also modulated the phosphorylation state of eIF-4E
(Manzella et al., 1991) suggesting that eIF-4F might be in a
signalling pathway by which insulin could regulate initiation of
translation of the heavy secondary structure in the ODC 5'
UTR.
Regulation of the eIF-4F initiation factor complex has re-
cently been described. PHAS I is an inhibitor of eIF-4E.
PHAS I forms a heterodimer with the eIF-4E subunit which
represses association of 4E with the eIF-4F complex. Phos-
phorylation of PHAS I induces dissociation of eIF-4E from
PHAS I allowing 4E to reassociate with p220/eIF-4A and in-
itiate transcriptional activity (Pause et al., 1994). Insulin-like
growth factor I and platlet derived growth factor increase
PHAS I phosphorylation and relieve the inhibition of trans-
lation produced by PHAS I on eIF-4E (Graves et al., 1995).
These eects are abolished by exposure of cells to the im-
munosuppressant, rapamycin. Rapamycin binds the FK 506
binding protein and this complex inhibits the mammalian
target of rapamycin (mTOR, also known as FRAP or RAFT).
By an unknown mechanism, rapamycin inhibits PHAS I
phosphorylation, an eect which maintains the PHAS-I/eIF-
4E complex and thereby limits translation. The eect of ra-
pamycin may be selective for repression of translation of an
mRNA family characterized by a polypyrimidine-rich tract
immediately following their N7-methylquanosine cap (Jeeries
et al., 1994). The human ODC mRNA contains a poly-
pyrimidine rich tract between bases 39 – 68 of its 5' UTR; 24 of
29 consecutive bases are pyrimidines. Because of the heavy
secondary structure of the 5' UTR of the ODC mRNA, its
sensitivity to growth factors such as insulin and its poly-
pyrimidine rich tract, we hypothesized the induction of ODC is
mediated by the action of the eIF-4F eukaryotic initiation
factor. If so, induction of ODC should be sensitive to rapa-
mycin. The eect of rapamycin on activity of the ODC protein
is described below and the results provide further evidence that
the eIF-4F initiation factor may indeed be involved in the
translational regulation of the ODC enzyme and thereby
polyamine synthesis.
Methods
The IEC-6 cell was cultured in Dulbecco’s Modified Eagles
Medium (DMEM)/5% foetal bovine serum (FBS) at 378C in
5% CO2 as previously described (Ginty & Seidel, 1989). Cells
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were serum deprived for 24 h before the beginning of each
experiment. Activity of ODC was assayed by determining the
rate of 14CO2 production (Ginty & Seidel, 1989) when
30,0006g supernatants of cell sonicates were incubated in the
presence of [14C]-ornithine (NEN, sp. act. 57.2 mCi mmol71).
Incorporation of [3,4-3H]-glutamine (NEN, 60 Ci mmol71)
into trichloro-acetic acid (TCA) precipitable material was de-
termined in IEC-6 cells incubated in glutamine-free DMEM as
previously described (Ginty et al., 1989). Uptake of putrescine
(NEN, 30.2 Ci mmol71) into the intracellular space was mea-
sured in subconfluent IEC-6 monolayers as previously de-
scribed (Scemma et al., 1993). Protein was measured by the
Bradford method (with gamma globulin as a standard)
(Bradford, 1976).
The immunosuppressant compounds rapamycin (Wyeth-
Ayerst, Philadelphia, PA), FK 506 (tacrolimus) and cyclos-
porin A (Biomol, Plymouth Meeting, PA) were dissolved in
ethanol at a stock concentration of 1 mM and stored at
7808C. These compounds were diluted to working con-
centrations in DMEM on the day of use. Cycloheximide was
purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.).
Results
Rapamycin was an eective inhibitor of ODC activity in IEC-6
cells (Figure 1). Concentrations as low as 3 nM inhibited
roughly 40% of the induction of ODC in response to 10% FBS
(Figure 1). However, increasing the concentration of rapa-
mycin to 1 mM produced only slightly more inhibition, 55% of
control, than did the 3 nM concentration. The peak in ODC
activity in the IEC-6 cell occurs about 4 h after the addition of
serum. Whether rapamycin, 10 nM, was added 30 min before
or 30 min after addition of 10% FBS made little dierence;
both treatment times resulted in an equivalent inhibition of
ODC activity. When rapamycin was added 3 h after enzyme
induction with FBS, the immunosuppressant was no longer
eective (Figure 2). Of the three immunosuppressants em-
ployed, only rapamycin was an eective inhibitor of ODC
(Figure 3). Neither FK-506 nor cyclosporin A blocked activity
of the enzyme. It should be noted that concentrations of
FK 506 from 0.01 to 1 mM and of cyclosporin A from 0.03 to
1.0 mM were tested and that all concentrations of the im-
munosuppressants were without eect on ODC activity. The
inhibitor of protein synthesis cycloheximide, 10 mg ml71,
produced a complete inhibition of ODC activity demonstrat-
ing the need for protein translation during induction of the
enzyme.
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Figure 1 Concentrations of rapamycin required to inhibit induction
of ornithine decarboxylase (ODC). Data are presented as %
inhibition of the induction of ODC produced by treatment of cells
with 10% foetal bovine serum (FBS) for 4 h. Each point represents
the mean of 5 to 7 determinations; vertical lines show s.e.mean.
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Figure 2 Time course of rapamycin action. Cells were serum
deprived for 24 h (Basal) and treated with 10% foetal bovine serum
(FBS). Rapamycin was added thirty min before or at various times
after treatment with FBS. One representative experiment which was
performed three times in duplicate with similar results.
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Figure 3 Eect of immunosuppressant pretreatment on the response
of IEC-6 cells to foetal bovine serum (FBS) induction of ornithine
decarboxylase activity (ODC). Cells were serum deprived for 24 h
(Basal) followed by exposure to 10 nM rapamycin (Rapa), 1 mM FK-
506 or 1mM cyclosporinA (CycloA). Thirty minutes later 10% foetal
bovine serum (FBS) was added to induce ODC enzyme. Data are
presented as % FBS control and each point represents the
mean+s.e.mean response of 5 – 7 determinations.
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The specificity of the eect of rapamycin on the activity of
ODC was demonstrated by determining the eects of the three
immunosuppressants on protein synthesis. The rate of protein
synthesis in serum stimulated cells was 3000 c.p.m. glutamine
incorporated/plate but only 1500 c.p.m./plate after exposure
of cells to 10 nM rapamycin (Figure 4). Both FK-506 and cy-
closporin A were equally eective inhibitors of protein synth-
esis. In contrast, cycloheximide completely blocked the
incorporation of glutamine into protein. Thus, while all three
immunosuppressants blocked protein synthetic rate to the
same degree, only rapamycin had an eect on ODC enzyme
activity.
The eect of rapamycin on IEC-6 cell proliferation was also
determined. Cells were plated at 40,000 cells/35 mm dish in the
absence and presence of 10 nM rapamycin. Control cells fol-
lowed a normal growth pattern but cells treated with rapa-
mycin did not divide during the six days following rapamycin
treatment (Figure 5). We have previously demonstrated that
10 mM putrescine, the product of the ODC catalysed reaction,
will reverse the growth inhibition produced by treatment with
the ODC inhibitor difluoromethylornithine (Ginty & Seidel,
1989). In addition, putrescine is as eective as 5% FBS in
moving cells from G0/G1 into the DNA synthetic phase (Ginty
et al., 1989). It was of interest to determine if addition of
putrescine would reverse the inhibition of proliferation pro-
duced by rapamycin; thus, on the seventh day of the experi-
ment 10 mM putrescine was added to the rapamycin containing
medium. Putrescine had no eect on the proliferative status of
the cells over the next three days in culture. On day 9 the
rapamycin/putrescine containing medium was replaced with
DMEM/5% FBS and cells maintained under these conditions
until day 12 after plating. Removal of the rapamycin was
followed by a vigorous proliferative response indicating the
eect of rapamycin was cytostatic and that the cells were still
fully capable of division. To insure that cells could still
transport polyamines after rapamycin treatment, a final ex-
periment was performed to determine the eect of rapamycin
on putrescine uptake. Cells were cultured in the presence of
100 nM rapamycin for 84 h before measurement of uptake of
exogenously supplied putrescine. Under control conditions the
IEC-6 cell transported 2,254+88 d.p.m. [3H]-putrescine/106
cells-15 min (n=11), whereas the rapamycin treated cells
transported 2,408+282 d.p.m. [3H]-putrescine/106 cells-15 min
(n=10). Thus, rapamycin was without eect on putrescine
transport and therefore the failure of putrescine to reverse the
cytostatic eect of rapamycin was not due to the ability of the
immunosuppressant to inhibit polyamine transport.
Discussion
These data support the hypothesis that the eIF-4F initiation
factor complex is in the pathway regulating the translation of
ODC mRNA. This intracellular signalling pathway leads to
activation of p70 S6 kinase (p70S6k) and phosphorylation of the
S6 ribosomal protein, the small subunit (40S) of eukaryotic
ribosomes (for review see Proud, 1996). S6 phosphorylation
is enhanced by a number of trophic stimuli such as hormones
and growth factors that stimulate protein synthesis. However,
in addition to the regulation of protein synthesis, these agents
modulate cellular proliferation. Overexpression of eIF-4E
is mitogenic (Smith et al., 1990). It produces tumourogenic
transformation (Lazarius-Karazas et al., 1990) in NIH3T3
cells and both enhanced rate of proliferation and morpholo-
gical changes in HeLa cells (DeBenedetti & Rhodes, 1990).
Rapamycin inhibited proliferation of the IEC-6 cell. Si-
milar eects have been observed in other cells including
vascular smooth muscle (Marx et al., 1995), phagocytes
(Cooper et al., 1994), mast cells (Tsai et al., 1993), hepato-
cytes (Francavilla et al., 1992). In the current experiments,
when rapamycin was removed from the medium, cells began
to proliferate normally suggesting the immunosuppressant
has a cytostatic eect in this epithelial cell line. Inhibition
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Figure 4 Eect of immunosuppressant treatment on incorporation
of [3,4-3H]-glutamine into acid precipitable material. Cells were
treated with 10 nM rapamycin (Rapa), 1 mM FK-506, 1 mM cyclospor-
inA (CycloA), or 10 mgml71 cycloheximide (Cyclohex) 30min before
the addition of 10% foetal bovine serum (FBS). After 2 h 1mCiml71
[3,4-3H]-glutamine was added and 2 h later the incubation was
stopped. Each point represents the mean+s.e.mean response of six
determinations.
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Figure 5 Eect of rapamycin on IEC-6 cell proliferation. Cells were
plated in DMEM/5% foetal bovine serum at 40,000 cells/plate in the
presence (&) or absence (^) of 10 nM rapamycin and a cell count
made daily for nine days. On days seven through nine, cells received
10 mM putrescine in addition to 10 nM rapamycin. After the cell count
on day nine, medium containing rapamycin/putrescine was replaced
with fresh DMEM/5% FBS containing neither agent for three days
(single square on day 12). The results are from one representative
experiment which was performed twice. Cell counts were performed
daily in duplicate plates.
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of ODC with difluoromethylornithine, a suicide substrate
inhibitor of the enzyme, leads to depletion of intracellular
polyamine stores and G1 cell cycle arrest; the eect is reversed
by addition of exogenous putrescine (Ginty & Seidel, 1989).
Although rapamycin partially blocked ODC enzyme activity,
an eect which may lead to polyamine depletion, the cyto-
static eect was not reversed by addition of exogenous pu-
trescine. Three possibilities can be presented: (1) either, in
addition to ODC, rapamycin inhibits the synthesis of a
number of proteins required for cell cycle progression or (2)
the partial ODC block did not deplete the cell of polyamines
or (3) the exogenously added putrescine was not transported
to the intracellular space. The first possibility is likely to be
true. For instance, eIF-4E increases nucleocytoplasmic
transport of cyclin D1 mRNA (Rousseau et al., 1996), an
eect which should be sensitive to rapamycin. The second
option, inhibition of ODC by rapamycin blocked only 50%
of enzyme activity and therefore was not accompanied by
intracellular polyamine depletion, may also be true but awaits
determination of the eect of rapamycin on intracellular
polyamine levels. The third possibility, that rapamycin in-
hibits polyamine transport, is unlikely as rapamycin did not
attenuate putrescine transport in the IEC-6 cell.
FK506, which binds to the same intracellular protein as
rapamycin, FKBP 12, yet does not inhibit p70S6k phosphor-
ylation, partially inhibited protein synthesis but was without
eect on ODC activity, demonstrating the specificity of rapa-
mycin inhibition of ODC. However, rapamycin, while specific,
blocked only 50% of the induction of ODC enzyme, even
though concentrations 100 times the eective concentration
were tested. The eect of rapamycin on the translation of other
messages including those for eEF-1 a, EF-2 and ribosomal
protein S6 is also not complete (Jeeries et al., 1994). This
observation suggests that either a second intracellular signal-
ling pathway is involved in regulation of ODC mRNA trans-
lation or rapamycin is unable to inhibit completely the
pathway leading to p70S6k phosphorylation. There is evidence
to support the latter possibility. Serum stimulation of Swiss
3T3 cells results in phosphorylation of seven sites on p70S6k.
Rapamcyin blocks phosphorylation of four of these sites but in
the presence of serum the remaining three sites continue to be
phosphorylated (Han et al., 1996). Phosphorylation of these
three sites in the presence of rapamycin may allow ODC
mRNA translation to proceed at a reduced rate and account
for the incomplete inhibition of enzyme activity observed in
our experiments.
Rapamycin was a generous gift from Wyeth-Ayerst Laboratories,
Philadelphia, PA. This work was supported in part by a grant from
the North Carolina Institute of Nutrition.
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